...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: AGM/rumour mill?'s
Reply New Message
Prev Message Back To Forum Threaded View Next Message

My guess is that it will be a "we are really excited about"......with a progress report on the science and ZERO progress on the business and liquidity side of things.

It's a no brainer. The CEO is not a competent business man.

GLTA

Very cynical Toinv       :(

4 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply